| Title : Latanoprost Acid-Brimonidine, a New Amide Prodrug for Glaucoma Management Based on the Concept of Sustained Release - Lin_2026_Molecules_31_ |
| Author(s) : Lin HJ , Su SH , Wu WC |
| Ref : Molecules , 31 : , 2026 |
| Abstract : |
| PubMedSearch : Lin_2026_Molecules_31_ |
| PubMedID: 42653864 |
| Title : Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-kappaB pathways - Su_2017_Naunyn.Schmiedebergs.Arch.Pharmacol_390_1189 |
| Author(s) : Su SH , Wu YF , Lin Q , Hai J |
| Ref : Naunyn Schmiedebergs Arch Pharmacol , 390 :1189 , 2017 |
| Abstract : |
| PubMedSearch : Su_2017_Naunyn.Schmiedebergs.Arch.Pharmacol_390_1189 |
| PubMedID: 28825114 |
| Title : Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K\/AKT signaling - Su_2016_Behav.Brain.Res_313_334 |
| Author(s) : Su SH , Wang YQ , Wu YF , Wang DP , Lin Q , Hai J |
| Ref : Behavioural Brain Research , 313 :334 , 2016 |
| Abstract : |
| PubMedSearch : Su_2016_Behav.Brain.Res_313_334 |
| PubMedID: 27424778 |